Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protocol-based Management of Perioperative Antithrombotic Therapy
NCT04852406Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2021
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib), heart valve disease (VHD), venous thromboembolism (VTE) and 3 more (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of a composite outcome including major bleeding and major adverse cardiovascular or cerebrovascular events at 30 days. Started Apr 2021; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)heart valve disease (VHD)venous thromboembolism (VTE)coronary heart disease (CHD)stroke
Beyond the preview
Go deeper on NCT04852406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04852406.